Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

January 07, 2026 07:18 ET | Source: Digital Currency X Technology Inc.

Digital Currency X Technology Expands Digital Asset Strategy Through Token Staking with EdgeAI Foundation

NEW YORK, Jan. 07, 2026 (GLOBE NEWSWIRE) -- Digital Currency X Technology Inc. (NASDAQ: DCX) ("DCX" or the "Company"), a digital asset treasury management company specializing in cryptocurrency...
January 07, 2026 07:00 ET | Source: Kamada Ltd.

Kamada Provides 2026 Annual Guidance of $200 - $205 Million in Revenues and $50 - $53 Million of Adjusted EBITDA, Representing Double-Digit Growth and Affirms 2025 Financial Guidance

2026 Guidance Represents Year-Over-Year Increase of 13% in Revenues and 23% in Adjusted EBITDA Based on Mid-Point of 2025 Annual Guidance2026 Annual Guidance is Based Solely on Continued Organic...
January 07, 2026 07:00 ET | Source: Liquidia Technologies, Inc.

Liquidia Corporation to Present at 44th Annual J.P. Morgan Healthcare Conference

MORRISVILLE, N.C., Jan. 07, 2026 (GLOBE NEWSWIRE) -- Liquidia Corporation (NASDAQ: LQDA) announced today that Dr. Roger Jeffs, Chief Executive Officer, will present at the 44th Annual J.P. Morgan...
January 07, 2026 07:00 ET | Source: Rezolute, Inc.

Rezolute Provides Insights from its Phase 3 sunRIZE Study in Congenital Hyperinsulinism and Shares Findings from its Expanded Access Program in Tumor Hyperinsulinism

Company believes that data from sunRIZE and the Expanded Access Program (EAP) provide evidence of activity of ersodetug in both indications Company plans to meet with FDA to align on path forward for...
January 07, 2026 07:00 ET | Source: Gain Therapeutics, Inc.

Gain Therapeutics Announces Announces Conference Participation During J.P. Morgan Healthcare Conference Week

BETHESDA, Md., Jan. 07, 2026 (GLOBE NEWSWIRE) -- Gain Therapeutics, Inc. (Nasdaq: GANX) (“Gain”, or the “Company”), a clinical-stage biotechnology company leading the discovery and development of...
January 07, 2026 07:00 ET | Source: Monte Rosa Therapeutics, Inc.

Monte Rosa Therapeutics Announces Positive Interim Phase 1 Data of MRT-8102 Demonstrating Profound CRP Reductions in Elevated CVD-risk Subjects

Monte Rosa Therapeutics Announces Positive Interim Phase 1 Data of MRT-8102 Demonstrating Profound CRP Reductions in Elevated CVD-risk Subjects
January 07, 2026 07:00 ET | Source: BioXcel Therapeutics

BioXcel Therapeutics Planning to Submit sNDA This Month Seeking FDA Approval for At-Home Use of IGALMI®

NEW HAVEN, Conn., Jan. 07, 2026 (GLOBE NEWSWIRE) -- BioXcel Therapeutics, Inc. (Nasdaq: BTAI), a biopharmaceutical company built on artificial intelligence (“AI”) to develop transformative medicines...
January 07, 2026 07:00 ET | Source: CECO Environmental Corp.

CECO Environmental Announces Upcoming Investor Conference

ADDISON, Texas, Jan. 07, 2026 (GLOBE NEWSWIRE) -- CECO Environmental Corp. (Nasdaq: CECO), a leading environmentally focused, diversified industrial company whose solutions protect people, the...
January 07, 2026 07:00 ET | Source: Syndax Pharmaceuticals, Inc.

Syndax and World Orphan Drug Alliance to Launch a Multi-Regional Managed Access Program, Expanding Access to Revuforj® (revumenib) Outside the U.S.

- Program will expand access in certain regions where Revuforj is not available commercially, as permitted by local regulations - - Program will be launched in parts of Eurasia, Central and Southeast...
January 07, 2026 07:00 ET | Source: Rumble, Inc.

Rumble and Tether Launch Crypto Wallet for Creator Economy

LONGBOAT KEY, Fla., Jan. 07, 2026 (GLOBE NEWSWIRE) -- Rumble Inc. (NASDAQ:RUM), the Freedom-First technology platform, and Tether, the largest company in the digital assets industry, today launched...